Incidence and outcomes of patients with late recurrence of Wilms' tumor

Pediatric Blood and Cancer

Volumn 60, Issue 10, 2013, Pages 1612-1615

  Malogolowkin, M H ^a   Spreafico, F ^b   Dome, J S ^c   van Tinteren, H ^d   Pritchard Jones, K ^e   van den Heuvel Eibrink, M M ^f   Bergeron, C ^g   de Kraker, J ^h   Graf, N ⁱ  

^a Children's Hospital of Wisconsin   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d Integraal Kankercentrum Amsterdam   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^g CENTRE LÉON BÉRARD   (France)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

ⁱ University Hospital for Children   (Germany)

Author keywords

Incidence; International experience; Late relapse; Outcomes; Wilms' tumor

Indexed keywords

ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INCIDENCE; LATE RECURRENCE; MALE; NEPHROBLASTOMA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR RECURRENCE;

INCIDENCE; INTERNATIONAL EXPERIENCE; LATE RELAPSE; OUTCOMES; WILMS' TUMOR;

ABDOMINAL NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS; WILMS TUMOR;

EID: 84881501574     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24604     Document Type: Article

References (24)

1. Green DM, Breslow NE, Beckwith JB, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1998; 16:237-245.
2. Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 2004; 22:1366-1372.
3. Tournade MF, Com-Nougué C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001; 19:488-500.
4. de Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumor (SIOP 93-01 trial): A randomised controlled trial. Lancet 2004; 364:1229-1235.
5. Mitchell C, Pritchard-Jones K, Shannon R, et al. immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumor: Results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer 2006; 42:2554-2562.
6. Wasilewski-Masker K, Liu Q, Yasui Y, et al. Late recurrence in pediatric cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009; 16:1709-1720.
7. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27:2328-2338.
8. Spreafico F, Pritchard Jones K, Malogolowkin MH, et al. Treatment of relapsed Wilms tumor: Lessons learned. Expert Rev Anticancer Ther 2009; 9:1807-1815.
9. Clausen N. Late-recurring Wilms' tumors. Prog Clin Biol Res 1982; 100:165-166.
10. Gallego-Melcón S, Sánchez de Toledo J, Doste D, et al. Late recurrent metastasis in Wilms' tumor. Med Pediatr Oncol 1994; 23:158-161.
11. Mikraki V, Yiannoulopoulos G, Moschovi M, et al. Late local recurrence of Wilms tumor. Med Pediatr Oncol 1996; 26:71.
12. Parambil JG, Aughenbaugh GL, Pereira TC, et al. Solitary pulmonary metastasis presenting 20 years after primary resection of Wilms tumor. Mayo Clin Proc 2005; 80:1514-1516.
13. Gibson PJ, Vadeboncoeur CM, Johnston DL. Relapse of Wilms' tumor 13 years after original diagnosis. J Pediatr Hematol Oncol 2005; 27:293-294.
14. Büyükpamukçu M, Köksal Y, Varan A, et al. Late recurrence in children with Wilms' tumor. Turk J Pediatr 2007; 49:226-230.
15. Pinarli FG, Oquz A, Karadeniz C, et al. Late relapsing Wilms tumor with rhabdomyomatous differentiation. Pediatr Blood Cancer 2009; 52:675-677.
16. Brown E, Hebra A, Jenrette J, et al. Successful treatment of late recurrent Wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response. J Pediatr Hematol Oncol 2010; 32:e241-e243.
17. Lee SY, Kim KR, Park JY, et al. Wilms' tumor with long-delayed recurrence: 25 years after initial treatment. Korean J Urol 2012; 53:288-292.
18. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2008; 100:1368-1379.
19. Sung L, Anderson JR, Donaldson SS, et al. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer 2004; 40:1878-1885.
20. Beckwith JB. Precursor lesions of Wilms tumor: Clinical and biological implications. Med Pediatr Oncol 1993; 21:158-168.
21. Vasquez R, Collini P, Meazza C, et al. Late relapse of embryonal rhandomyosarcoma, botryoid variant, of the vagina. Pediatr Blood Cancer 2008; 51:140-141.
22. Dome JS, Liu T, Krasin M, et al. Improved survival for patients with recurrent Wilms tumor: The experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol 2002; 24:192-198.
23. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007; 48:493-499.
24. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2008; 50:236-241.